Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

10.39USD
7:39pm BST
Change (% chg)

$-0.46 (-4.24%)
Prev Close
$10.85
Open
$10.85
Day's High
$10.85
Day's Low
$10.39
Volume
36,119
Avg. Vol
160,241
52-wk High
$27.19
52-wk Low
$8.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 29.49 -0.313
FY 2018 Dec '18 11.47 -0.715
Sep '18 12.51 -0.534
Jun '18 21.34 -0.345
Mar '18 14.18 -0.401
FY 2017 Dec '17 27.07 -0.653
Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 10 16.45 25.38 8.00 18.50
Quarter Ending Dec-19 10 15.18 26.25 8.00 13.50
Year Ending Dec-19 10 77.71 103.24 53.50 67.17
Year Ending Dec-20 10 59.32 103.21 0.00 91.39
Earnings (per share)
Quarter Ending Sep-19 11 -0.60 -0.30 -0.90 -0.45
Quarter Ending Dec-19 11 -0.66 -0.48 -0.97 -0.58
Year Ending Dec-19 11 -2.14 -1.67 -3.02 -2.44
Year Ending Dec-20 11 -2.84 -1.99 -4.21 -2.73
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.41 32.67
P/E High - Last 5 Yrs. -- 147.75 47.29
P/E Low - Last 5 Yrs. -- 48.01 23.88
Beta -- 1.09 0.89
Price to Sales (TTM) 26.31 49.46 7.92
Price to Book (MRQ) 15.16 10.14 5.39
Price to Tangible Book (MRQ) 16.00 13.75 6.71
Price to Cash Flow (TTM) -- 55.97 24.37
% Owned Institutions 76.32 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.00 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 205.69 12.24
Sales (TTM) vs TTM 1 Yr. Ago 225.95 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.81 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 75.26 43.01
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 5.62 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.58 10.21
Total Debt to Equity (MRQ) 0.00 31.20 14.56
Interest Coverage (TTM) -- -43.39 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.07 52.21
Gross Margin - 5 Yr. Avg. -- 60.31 50.40
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -110.44 13.16
Operating Margin (TTM) -209.53 -184.27 6.88
Operating Margin - 5 Yr. Avg. -- -126.89 8.97
Pre-Tax Margin (TTM) -206.33 -175.02 6.08
Pre-Tax Margin - 5 Yr. Avg. -- -132.65 9.26
Net Profit Margin (TTM) -206.33 -181.72 2.72
Net Profit Margin - 5 Yr. Avg. -- -137.02 5.63
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 7,672,423 887,716,663
Net Income/Employee (TTM) -797,026 533,977 101,894,138
Receivable Turnover (TTM) 103.37 6.28 5.94
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.11 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 6.42 11.18
Return on Assets - 5 Yr. Avg. -- 5.51 12.34
Return on Investment (TTM) -26.13 8.94 14.49
Return on Investment - 5 Yr. Avg. -- 6.84 16.03
Return on Equity (TTM) -81.04 10.07 15.79
Return on Equity - 5 Yr. Avg. -- 8.42 17.02
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 99 99
13 Week 32.88 26.41 99 95
26 Week 25.44 15.90 99 97
52 Week 39.97 18.64 99 70
YTD 95.63 71.81 99 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.70%
# of Holders: 170
Total Shares Held: 38,377,348
3 Mo. Net Change: -158,743
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 11
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.